SolgoBio Decides on Third-Party Allocation Paid-in Capital Increase Worth 6 Billion KRW

KOSDAQ-listed company Solgo Bio announced on the 14th that it has decided to raise 6 billion KRW through a third-party allotment paid-in capital increase to secure operating funds.

12 million new common shares will be issued at 500 KRW per share. The third-party allotment recipient is MDS Intelligence Co., Ltd.

This content was produced with the assistance of AI translation services.